Sign up to save your podcasts
Or
Share Omidenepag: A New Category of Topical Glaucoma Therapy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Omidenepag: A New Category of Topical Glaucoma Therapy
Drs. Amanda Bicket and Lori Provencher join Dr. Andrew Pouw to discuss omidenepag isopropyl (Omlonti), the recently FDA-approved eye drop for treating elevated IOP in patients with primary open-angle glaucoma or ocular hypertension.
For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
View all episodes
By American Academy of Ophthalmology
4.9
4747 ratings
Drs. Amanda Bicket and Lori Provencher join Dr. Andrew Pouw to discuss omidenepag isopropyl (Omlonti), the recently FDA-approved eye drop for treating elevated IOP in patients with primary open-angle glaucoma or ocular hypertension.
For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
More shows like Experts InSight
View all
Ophthalmology off the Grid by Eyetube
41 Listeners
Straight From The Cutter's Mouth: A Retina Podcast
97 Listeners
New Retina Radio by Eyetube
16 Listeners
JAMA Ophthalmology Author Interviews
5 Listeners
The Retina Channel Podcast
11 Listeners
Eyes For Ears
271 Listeners
CRST: The Podcast
9 Listeners
American Journal of Ophthalmology Podcasts Collection
12 Listeners
Headlight in the fog: The Uveitis Podcast
20 Listeners
Pupil Pod
8 Listeners
RETINA Journal Podcasts
10 Listeners
Ophthalmology Journal
17 Listeners
Mayo Clinic Ophthalmology Podcast
16 Listeners
Cataract Coach with Uday Devgan MD
16 Listeners
ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum
0 Listeners